PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 10, 2025Archives of Medical Research1 citationsOpen Access

Unveiling Longitudinal Weight Dynamics in Type 2 Diabetes: Insights From a Comprehensive Care Program

View Full Paper
AGAna Cristina García-UlloaLPLiliana Pérez-PeraltaLULuz E. Urbina-Arronte

Key Points

  • At 3 years, 35.5% of participants lost weight, indicating varied responses to multidisciplinary intervention.
  • Higher baseline HbA1c was linked to weight gain, with an odds ratio of 1.14 (95% CI 1.03-1.26, p=0.008).
  • Longer diabetes duration and higher BMI were associated with weight loss, with odds ratios of 0.81 and 0.90 respectively.
  • Identifying predictors of weight change may guide tailored strategies for managing type two diabetes.

Abstract

Overweight and obesity are prevalent conditions that contribute to significant health problems, including type two diabetes (T2D). Moderate weight loss improves metabolic control and cardiovascular risk. We aimed to identify the demographic and clinical characteristics of patients with T2D who experienced weight changes after a multidisciplinary intervention. We analyzed 622 patients with complete 3-year follow-up information. Inclusion criteria were less than 5-years since diabetes diagnosis and an absence of disabling chronic complications. Descriptive statistics, ANOVA or Kruskal-Wallis tests were used for group comparisons, and logistic regression to identify predictors of weight change. Participants were 56.2 % women, with an average age of 55.8 ± 10.5 years. 53 % were overweight and 47 % were obese at baseline. At 3-years, 35.5 % lost weight, 33.9 % maintained weight, and 30.5 % gained weight; 16.6 % achieved a normal weight. Patients who gained weight were younger than those who lost or maintained it (60 vs. 61 years, p = 0.04). Higher baseline HbA1c (OR 1.14, 95 % CI 1.03-1.26, p = 0.008) and lower quality of life at three months (OR 1.48, 95 % CI 0.95-2.28, p = 0.07) were associated with weight gain. Higher baseline BMI (OR 0.90, 95 % CI 0.85-0.95, p < 0.001), longer diabetes duration (OR 0.81, 95 % CI 0.70-0.94, p = 0.005), and iSGLT2 treatment were linked to weight loss. Only 16 % of patients achieved normal weight after 3-years: 35.5 % lost weight, 33.9 % maintained their weight, and 30.5 % gained weight. Identifying predictors of weight change may guide targeted interventions in diabetes care.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

García-Ulloa et al. (2025) studied this question.

synapsesocial.com/papers/68c1cc2e54b1d3bfb60f4491https://doi.org/10.1016/j.arcmed.2025.103271
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults2024 · 2,328 citations
  2. 2Impact of weight gain on outcomes in type 2 diabetes2011 · 93 citations
  3. 3European Practical and Patient-Centred Guidelines for Adult Obesity Management in Primary Care2019 · 506 citations
  4. 4Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes2014 · 194 citations
  5. 5The Carbohydrate-Insulin Model of Obesity2018 · 444 citations